Emotional Processes and Speech Control for Stuttering
Trial Summary
What is the purpose of this trial?
This study will compare speech variability between preschool-age children who stutter and typically fluent, age-matched peers. Differences in emotional reactivity, regulation and speech motor control have been implicated in stuttering development in children. This study seeks to understand further how these processes interact. Children will repeat a simple phrase after viewing age-appropriate images of either negative or neutral valence to assess speech motor control.
Will I have to stop taking my current medications?
If your child is taking medications that affect brain functions, like seizure medications, they will need to stop taking them to participate in the trial.
What data supports the effectiveness of this treatment for stuttering?
The research suggests that emotional factors, such as anxiety and negative emotions, play a significant role in stuttering. Treatments that address these emotional aspects, like viewing pictures with different emotional valences, may help reduce negative emotions and improve speech fluency, as seen in the decrease of negative emotions in severe stuttering cases.12345
Is the treatment for stuttering involving emotional processes and speech control safe for humans?
How does this treatment for stuttering differ from other treatments?
This treatment is unique because it focuses on the emotional processes and speech control by examining the role of the amygdala (a part of the brain involved in emotions) in stuttering. It aims to address the emotional and neural aspects of stuttering, which are not typically the focus of standard speech therapy treatments.410111213
Research Team
Victoria Tumanova, PhD
Principal Investigator
Syracuse University
Eligibility Criteria
This trial is for preschool-age children who stutter but do not have other speech-language disorders, neurological diseases, or oral-facial structural abnormalities like cleft lip/palate. They should be primarily English speakers with normal hearing and vision (with glasses if needed), and not on medications affecting neural functions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Condition
Children repeat a simple phrase after viewing images with negative or neutral valence to assess speech motor control
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Speaking after viewing blank screen pictures
- Speaking after viewing pictures with negative and neutral valence
- Speaking after viewing pictures with negative valence
Find a Clinic Near You
Who Is Running the Clinical Trial?
Syracuse University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator